117 Followers on Owler

Elcelyx is a developer of novel and re-positioning therapies for clinical developmental studies...

Read more

Elcelyx is a developer of novel and re-positioning therapies for clinical developmental studies...

Read more
Elcelyx Therapeutics President & CEO: Alain D. Baron

President & CEO

Alain D. Baron

CEO Approval Rating

79/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
93.3M

News

May 29, 2019
Business Wire
Press Release: Elcelyx Therapeutics : Anji Pharmaceuticals Acquires Late-Stage Clinical Asset and Readies for Ph3 Trials in Type 2 Diabetes with Chronic Kidney Disease
Oct 06, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Jul 31, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 20, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09032018 Prices from USD $250
Aug 02, 2017
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27072017 Prices from USD $250
Apr 05, 2017
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 16032017 Prices from USD $250
Nov 14, 2016
Drug Development Technology
Elcelyx Therapeutics: Elcelyx Therapeutics reports positive Phase IIb study results of Metformin DR to treat type 2 diabetes
Nov 11, 2016
PharmaLeaders
Elcelyx Therapeutics: Elcelyx unveils positive results in phase 2b study of Metformin DR in type 2 diabetes
Oct 12, 2016
BioSpace
Elcelyx Therapeutics: Elcelyx Therapeutics Elects To Board Of Directors
May 25, 2016
BioSpace
Elcelyx Therapeutics: Elcelyx Therapeutics Completes Enrollment In Phase 2b Clinical Trial Of Metformin Delayed Release For Type 2 Diabetes

Elcelyx Therapeutics Competitors

1
2
3
4
5
6
7
8
9
10
See 17+ competitors

Elcelyx Therapeutics News

Elcelyx Therapeutics Press Releases

Elcelyx Therapeutics Headquarters

11975 El Camino Real Suite 305

San Diego, California92130

858-876-1814

Driving Directions »

Elcelyx Therapeutics Summary

ABOUT

Overview

Elcelyx is a developer of novel and re-positioning therapies for clinical developmental studies. Elcelyx Therapeutics was founded in 2009. Elcelyx Therapeutics' headquarters is located in San Diego, California, USA 92130. Elcelyx Therapeutics' Presid...

CEO

Elcelyx Therapeutics's President & CEO, Alain D. Baron, currently has an approval rating of 79%. Elcelyx Therapeutics's primary competitors are Intarcia, XBiotech, Valeritas and 14 more.

Acquisitions

There have been no acquisitions found related to Elcelyx Therapeutics

Investments

Recent investment data cannot be found related to Elcelyx Therapeutics

Frequently Asked Questions about Elcelyx Therapeutics

  1. When was Elcelyx Therapeutics founded?

    Elcelyx Therapeutics was founded in 2009
  2. Who is Elcelyx Therapeutics's CEO?

    Elcelyx Therapeutics's CEO is Alain D. Baron
  3. How much revenue does Elcelyx Therapeutics generate?

    Elcelyx Therapeutics generates $4.4M in revenue
  4. How much funding does Elcelyx Therapeutics have?

    Elcelyx Therapeutics has historically raised $93.3M in funding
  1. Where is Elcelyx Therapeutics's headquarters?

    Elcelyx Therapeutics's headquarters is in San Diego California, USA
  2. How many employees does Elcelyx Therapeutics have?

    Elcelyx Therapeutics has 40 employees
  3. What sector does Elcelyx Therapeutics operate in?

    Elcelyx Therapeutics is in Health Care Services
  4. Who are Elcelyx Therapeutics's competitors?

    Elcelyx Therapeutics's top competitors are Intarcia, XBiotech, Valeritas

Trending Companies